ClearNote Health

Empowering early cancer detection

San Diego, United States · Founded 2016 · $193.8M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$193.8M
Last Round
$50.0M Series AMay 2026
Rounds
4

About

ClearNote Health develops blood-based early cancer detection tests and epigenomics software using cell-free DNA methylation. Its Avantect tests target high-mortality cancers with limited detection options, including pancreatic and ovarian cancer. The company's Virtuoso epigenomics platform supports biopharma drug discovery.

Summary

ClearNote Health is a Healthcare company based in San Diego, United States, founded in 2016. It has raised $193.8M in total across 4 rounds, most recently a $50.0M Series A round in May 2026. Investors include Mattias Westman.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2026
$50.0M

Sign up to see all 4 rounds

Series C through Series D — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ClearNote Health on Indexed.vc
<a href="https://indexed.vc/companies/clearnote-health"><img src="https://indexed.vc/api/badge/company/clearnote-health" alt="ClearNote Health on Indexed.vc" width="260" height="76" /></a>